What's going to be in the ctdna readout?I bet I can predict
What's going to be in the ctdna readout?I bet I can predict orr or close if it's a complete readout. Timelines etc.
They know orr right now
Maybe they give us some
Maybe cps on caml and ctc
It depends how close they stretch to late breaking if at all.
They really don't have to try and juice the share price right now anyway because they are not desperate or would have asked for more shares already.
Cydy is not going to be the ones worried about making a deal soon.
We got the thing.
7
CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Top 5 Most Recently Viewed Articles
Overview of the EMC Filtration Market The EMC filtration market is an essential segment aimed at providing electromagnetic interference (EMI) protection across various industries. Currently valued at around USD 1.50 billion, the market is projected to grow significantly, reaching USD 2.35 billion by 2032. This growth reflects a compound annual growth rate (CAGR) of 5.15%,...
Continue Reading
Boosting Connections with the Hispanic Community Microsoft has announced a significant partnership with BODEN Agency, a prominent Hispanic+ communications agency, to enhance its outreach to the Hispanic community across the United States. This strategic alliance aims to make meaningful connections through targeted communication strategies that resonate with this vital...
Continue Reading
Recent Actions by SoundHound AI's COO Michael Zagorsek, the Chief Operating Officer of SoundHound AI, Inc. (NASDAQ: SOUN), recently made headlines by selling a substantial amount of company stock worth over $200,000. He sold 42,001 shares at a price of $4.8795 per share, bringing the total to approximately $204,943. This sale was mainly to cover tax withholding...
Continue Reading
BioBam Introduces OmicsBox Version 3.4 BioBam, a renowned leader in the field of bioinformatics solutions, has recently rolled out the latest version of its innovative software, OmicsBox 3.4. This significant upgrade was showcased at a prominent conference dedicated to plant and animal genomics. With this release, BioBam is addressing the pressing and evolving challenges...
Continue Reading
Seizing Market Opportunities During a Downturn In today's unpredictable financial landscape, marked by trade wars, tariffs, and economic concerns, many investors face anxiety about their portfolios. The recent market downturn has touched almost every sector, leading to widespread fear and panic among investors. However, amidst this chaos, there are potential opportunities...
Continue Reading
